Golzy Nima, Fernandes Stuti, Sharim Justin, Tank Rikin, Tazelaar Henry D, Epstein Howard E, Tapson Victor, Hage Antoine
Department of Internal Medicine, David Geffen School of Medicine at UCLA, 757 Westwood Plaza, Suite 7501, Los Angeles, CA 90095, USA.
Pulmonary Hypertension Program, Department of Pulmonology, Cedars-Sinai Medical Center, 127 South San Vicente Blvd, Suite A3600, Los Angeles, CA 90048, USA; Department of Solid Organ Transplant Cardiology, Cedars-Sinai Medical Center, 127 South San Vicente Blvd, Suite A3600, Los Angeles, CA 90048, USA.
Respir Med Case Rep. 2016 Sep 27;20:10-13. doi: 10.1016/j.rmcr.2016.09.005. eCollection 2017.
Pulmonary veno-occlusive disease (PVOD) is rare condition which can lead to severe pulmonary hypertension, right ventricular dysfunction, and cardiopulmonary failure. The diagnosis of PVOD can be challenging due to its nonspecific symptoms and its similarity to idiopathic pulmonary arterial hypertension and interstitial lung disease in terms of diagnostic findings. This case describes a 57 year old female patient who presented with a 5-month history of progressive dyspnea on exertion and nonproductive cough. Workup at another hospital was nonspecific and the patient underwent surgical lung biopsy due to concern for interstitial lung disease. She subsequently became hemodynamically unstable and was transferred to our hospital where she presented with severe hypoxemia, hypotension, and suprasystemic pulmonary artery pressures. Preliminary lung biopsy results suggested idiopathic pulmonary arterial hypertension and the patient was started on vasodilating agents, including continuous epoprostenol infusion. Pulmonary artery pressures decreased but remained suprasystemic and the patient did not improve. Final review of the biopsy by a specialized laboratory revealed a diagnosis of PVOD after which vasodilating therapy was immediately weaned off. Evaluation for dual heart-lung transplantation was begun. The patient's hospital course was complicated by hypotension requiring vasopressors, worsening right ventricular dysfunction, and acute kidney injury. During the transplantation evaluation, the patient decided that she did not want to undergo continued attempts at stabilization of her progressive multi-organ dysfunction and she was transitioned to comfort care. She expired hours after removing inotropic support.
肺静脉闭塞病(PVOD)是一种罕见疾病,可导致严重的肺动脉高压、右心室功能障碍和心肺衰竭。PVOD的诊断具有挑战性,因为其症状不具特异性,且在诊断结果方面与特发性肺动脉高压和间质性肺疾病相似。本病例描述了一名57岁女性患者,有5个月进行性劳力性呼吸困难和干咳病史。在另一家医院的检查无特异性,因怀疑间质性肺疾病,患者接受了外科肺活检。随后她出现血流动力学不稳定,被转至我院,表现为严重低氧血症、低血压和肺动脉压高于体循环压力。初步肺活检结果提示特发性肺动脉高压,患者开始使用血管扩张剂治疗,包括持续静脉输注依前列醇。肺动脉压下降但仍高于体循环压力,患者病情未改善。一家专业实验室对活检结果的最终复查显示诊断为PVOD,之后立即停用血管扩张剂治疗。开始评估心肺联合移植。患者的住院过程因低血压需用血管升压药、右心室功能障碍恶化和急性肾损伤而复杂化。在移植评估期间,患者决定不再继续尝试稳定其进行性多器官功能障碍,转而接受舒适护理。在撤除强心支持数小时后,她死亡。